Artificial Intelligence applied to the diagnosis and treatment of rare diseases

That Artificial Intelligence is coming to our daily lives is nothing new. We have all [...]

Tribute to Severo Ochoa, the Spanish biochemist who received the Nobel Prize for discovering the enzymes involved in RNA synthesis.

Of Spanish origin, the small and idyllic town of Luarca (Asturias) was the birthplace of [...]

Spanish pharmaceutical industry, third largest exporter with 53% growth to 2022

We love to share good news from the sector. On this occasion, we share the [...]

#8M, #InternationalWomensDay: “For an inclusive digital world”

One more year, we celebrate #InternationalWomensDay: a day that not only commemorates and pays tribute [...]

Rare Disease Day

Oligofastx is a project born from a need: to offer a therapeutic pathway based on [...]

Metaverse opens new opportunities for research and collaboration

If there is one word that distinguishes OLIGOFASTX and its philosophy, it is innovation. Thanks [...]

The contribution of women in science

Since 2015, the International Day of Women and Girls in Science has been celebrated every [...]

World Cancer Day

As it could not be otherwise, from Oligofastx we join in the celebration of the [...]

Leber Congenital Amaurosis

Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner [...]

A 2023 with a hopeful look at therapeutic oligonucleotides

The last few years have been a true revolution in terms of discoveries and initiatives [...]

Cancer cachexia

Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, [...]

Providing solutions for rare diseases: a priority for the UN

Perhaps the definition is not the most accurate, but in reality a rare disease does [...]

Goodbye 2022, welcome 2023

In the last days of the year, it is time to review everything we have [...]

Innovative and sustainable production of biological molecules

The Oligofastx project covers all areas, from start to finish, of the process of developing [...]

Personalized treatments for rare diseases with oligonucleotides pose universal challenges

There is no doubt that oligonucleotide therapies aimed at providing answers and improving the quality [...]

Oligonucleotides, the language of life in small doses

A technological revolution can start with a key concept, the application of an equation or, [...]

Solid-phase synthesis in the amplification and sequencing of nucleic acids

The Oligofastx project covers the different phases of the development of oligonucleotide-based therapies, from design [...]

Oligonucleotides for curing osteoporosis, premature aging in children and hepatitis B

OLIGOFASTX follows with great interest all the recent advances in the work with oligonucleotides, not [...]

Maurice Wilkins, the third man of the double helix

History is peppered with stories, legends and tales. And as in all of them, any [...]

Anaplastic thyroid cancer: the most aggressive and lethal type of cancer

Thyroid cancer is a common malignancy of the endocrine system. There are four types: Papillary [...]

Guillain-Barré Syndrome: when the immune system attacks peripheral nerves

Today we are going to talk about one of those diseases classified as rare, for [...]

The Most Excellent Nobel Laureates 2022: these were the winners in the categories of Chemistry and Medicine

The work of the most renowned scientists, artists and diplomats is rewarded every year at [...]

Retinitis pigmentosa, a genetic vision pathology

Every last Sunday of September is celebrated the International Retinitis Pigmentosa Day, one of the [...]

Steinert’s myotonic dystrophy: when muscles become unresponsive

Today is International Myotonic Dystrophy Day, a rare disease with no treatment or cure to [...]

The OLIGOFASTX project is born

The project, subsidised by the CDTI with 5.4 million euros and a final budget of [...]